SI1940409T1 - Nove zdravilske kombinacije za zdravljenje bolezni dihalnih poti - Google Patents

Nove zdravilske kombinacije za zdravljenje bolezni dihalnih poti

Info

Publication number: SI1940409T1
Authority: SI; Slovenia
Prior art keywords: treatment; respiratory disorders; novel pharmaceutical; pharmaceutical combinations; combinations
Prior art date: 2005-10-10

Application number

SI200630836T

Other languages

English (en)

Inventor

Thierry Bouyssou

Michael P Pieper

Andreas Schnapp

Original Assignee

Boehringer Ingelheim Int

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-10-10

Filing date

2006-10-06

Publication date

2010-12-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35658907&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1940409(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-10-06 Application filed by Boehringer Ingelheim Int, Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Int

2010-12-31 Publication of SI1940409T1 publication Critical patent/SI1940409T1/sl

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, ***e
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Otolaryngology (AREA)
Dispersion Chemistry (AREA)
Emergency Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

SI200630836T 2005-10-10 2006-10-06 Nove zdravilske kombinacije za zdravljenje bolezni dihalnih poti SI1940409T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP05109374		2005-10-10
PCT/EP2006/067122 WO2007042467A1 (de)	2005-10-10	2006-10-06	Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen
EP06807024A EP1940409B1 (de)	2005-10-10	2006-10-06	Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen

Publications (1)

Publication Number	Publication Date
SI1940409T1 true SI1940409T1 (sl)	2010-12-31

Family

ID=35658907

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200630836T SI1940409T1 (sl)	2005-10-10	2006-10-06	Nove zdravilske kombinacije za zdravljenje bolezni dihalnih poti

Country Status (23)

Country	Link
US (10)	US20070086957A1 (sl)
EP (1)	EP1940409B1 (sl)
JP (1)	JP5081158B2 (sl)
KR (1)	KR101344225B1 (sl)
CN (1)	CN101282729A (sl)
AR (1)	AR057148A1 (sl)
AT (1)	ATE482709T1 (sl)
AU (1)	AU2006301329B9 (sl)
BR (1)	BRPI0617269A2 (sl)
CA (1)	CA2624584C (sl)
CY (1)	CY1111022T1 (sl)
DE (1)	DE502006007982D1 (sl)
DK (1)	DK1940409T3 (sl)
ES (1)	ES2353404T3 (sl)
IL (1)	IL190652A (sl)
NZ (1)	NZ567547A (sl)
PL (1)	PL1940409T3 (sl)
PT (1)	PT1940409E (sl)
RU (1)	RU2436578C2 (sl)
SI (1)	SI1940409T1 (sl)
TW (1)	TWI396541B (sl)
WO (1)	WO2007042467A1 (sl)
ZA (1)	ZA200801667B (sl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7056916B2 (en) *	2002-11-15	2006-06-06	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Medicaments for the treatment of chronic obstructive pulmonary disease
US20050272726A1 (en) *	2004-04-22	2005-12-08	Boehringer Ingelheim International Gmbh	Novel medicaments for the treatment of respiratory diseases
US20050255050A1 (en) *	2004-05-14	2005-11-17	Boehringer Ingelheim International Gmbh	Powder formulations for inhalation, comprising enantiomerically pure beta agonists
US7220742B2 (en) *	2004-05-14	2007-05-22	Boehringer Ingelheim International Gmbh	Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
AU2006281449B2 (en) *	2005-08-15	2013-01-31	Boehringer Ingelheim International Gmbh	Method for producing betamimetics
EP2413902B1 (en)	2009-03-18	2019-07-17	Incarda Therapeutics, Inc.	Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
WO2014016548A2 (en)	2012-07-27	2014-01-30	Cipla Limited	Pharmaceutical composition
WO2014056840A1 (en)	2012-10-09	2014-04-17	Boehringer Ingelheim International Gmbh	Beta-2-adrenoceptor agonist for the treatment of cough
AU2017215189A1 (en)	2016-02-01	2018-08-02	Incarda Therapeutics, Inc.	Combining electronic monitoring with inhaled pharmacological therapy to manage cardiac arrhythmias including atrial fibrillation
CN110062625A (zh) *	2016-12-12	2019-07-26	勃林格殷格翰国际有限公司	尼达尼布通过与奥达特罗共给予用于治疗间质性肺病的方法
EP3621616A4 (en)	2017-05-10	2021-01-13	InCarda Therapeutics, Inc.	UNIT DOSE, AEROSOLS, KITS AND METHODS FOR TREATMENT OF HEART DISEASE BY PULMONAL ADMINISTRATION
EP3768378A4 (en)	2018-03-22	2021-11-17	InCarda Therapeutics, Inc.	INNOVATIVE METHOD OF SLOWING THE VENTRICULAR RATE
US11007185B2 (en)	2019-08-01	2021-05-18	Incarda Therapeutics, Inc.	Antiarrhythmic formulation
WO2021211850A1 (en) *	2020-04-16	2021-10-21	Anovent Pharmaceutical(U.S.)., Llc	Inhalable formulation of a solution containing olodaterol

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4570630A (en)	1983-08-03	1986-02-18	Miles Laboratories, Inc.	Medicament inhalation device
US4811731A (en)	1985-07-30	1989-03-14	Glaxo Group Limited	Devices for administering medicaments to patients
SE453566B (sv)	1986-03-07	1988-02-15	Draco Ab	Anordning vid pulverinhalatorer
SG45171A1 (en)	1990-03-21	1998-01-16	Boehringer Ingelheim Int	Atomising devices and methods
AU680227B2 (en) *	1992-12-09	1997-07-24	Boehringer Ingelheim Pharmaceuticals, Inc.	Stabilized medicinal aerosol solution formulations
DE4318455A1 (de)	1993-06-03	1994-12-08	Boehringer Ingelheim Kg	Kapselhalterung
TW537903B (en) *	1995-06-27	2003-06-21	Boehringer Ingelheim Kg	New stable pharmaceutical preparation for producing propellant gas-free aerosols
DE19536902A1 (de)	1995-10-04	1997-04-10	Boehringer Ingelheim Int	Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
CN1245974C (zh) *	2000-06-28	2006-03-22	特瓦制药工业有限公司	卡维地洛
AU2002214996B2 (en)	2000-10-12	2007-03-15	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
US20020151541A1 (en) *	2000-10-31	2002-10-17	Michel Pairet	Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
US20020122773A1 (en) *	2000-12-20	2002-09-05	Michel Pairet	Pharmaceutical compositions based on anticholinergics and dopamine agonists
US20020111363A1 (en) *	2000-10-31	2002-08-15	Karin Drechsel	Inhalable formulation of a solution containing a tiotropium salt
US20020193392A1 (en) *	2000-11-13	2002-12-19	Christel Schmelzer	Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
NZ530690A (en)	2001-06-22	2005-05-27	Boehringer Ingelheim Pharma	Crystalline anticholinergic, proccesses for preparing it and its use for preparing a pharmaceuticaal composition
DE10212264A1 (de) *	2002-03-20	2003-10-02	Boehringer Ingelheim Pharma	Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
DE10214263A1 (de) *	2002-03-28	2003-10-16	Boehringer Ingelheim Pharma	HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
US20030225089A1 (en) *	2002-04-10	2003-12-04	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
DE10253282A1 (de) *	2002-11-15	2004-05-27	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
US7056916B2 (en) *	2002-11-15	2006-06-06	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Medicaments for the treatment of chronic obstructive pulmonary disease
US7250426B2 (en) *	2002-11-29	2007-07-31	Boehringer Ingelheim Pharma Gmbh & Co Kg	Tiotropium-containing pharmaceutical combination for inhalation
US20050025718A1 (en) *	2003-07-31	2005-02-03	Boehringer Ingelheim International Gmbh	Medicaments for inhalation comprising an anticholinergic and a betamimetic
US7244728B2 (en) *	2004-03-17	2007-07-17	Boehringer Ingelheim International Gmbh	Long acting betamimetics for the treatment of respiratory diseases
ES2523518T3 (es) *	2004-04-22	2014-11-26	Boehringer Ingelheim International Gmbh	Nuevas combinaciones farmacológicas para el tratamiento de enfermedades de las vías respiratorias
US20050272726A1 (en) *	2004-04-22	2005-12-08	Boehringer Ingelheim International Gmbh	Novel medicaments for the treatment of respiratory diseases
US7220742B2 (en) *	2004-05-14	2007-05-22	Boehringer Ingelheim International Gmbh	Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US20050255050A1 (en) *	2004-05-14	2005-11-17	Boehringer Ingelheim International Gmbh	Powder formulations for inhalation, comprising enantiomerically pure beta agonists
US20050256115A1 (en) *	2004-05-14	2005-11-17	Boehringer Ingelheim International Gmbh	Aerosol formulation for the inhalation of beta-agonists

2006
- 2006-10-05 TW TW095137032A patent/TWI396541B/zh active
- 2006-10-05 US US11/543,694 patent/US20070086957A1/en not_active Abandoned
- 2006-10-06 JP JP2008535000A patent/JP5081158B2/ja active Active
- 2006-10-06 EP EP06807024A patent/EP1940409B1/de active Active
- 2006-10-06 CN CNA2006800377355A patent/CN101282729A/zh active Pending
- 2006-10-06 SI SI200630836T patent/SI1940409T1/sl unknown
- 2006-10-06 DK DK06807024.2T patent/DK1940409T3/da active
- 2006-10-06 RU RU2008117834/15A patent/RU2436578C2/ru active
- 2006-10-06 AU AU2006301329A patent/AU2006301329B9/en active Active
- 2006-10-06 AT AT06807024T patent/ATE482709T1/de active
- 2006-10-06 BR BRPI0617269-5A patent/BRPI0617269A2/pt not_active Application Discontinuation
- 2006-10-06 AR ARP060104404A patent/AR057148A1/es not_active Application Discontinuation
- 2006-10-06 DE DE502006007982T patent/DE502006007982D1/de active Active
- 2006-10-06 PL PL06807024T patent/PL1940409T3/pl unknown
- 2006-10-06 CA CA2624584A patent/CA2624584C/en not_active Expired - Fee Related
- 2006-10-06 ES ES06807024T patent/ES2353404T3/es active Active
- 2006-10-06 NZ NZ567547A patent/NZ567547A/en unknown
- 2006-10-06 WO PCT/EP2006/067122 patent/WO2007042467A1/de active Application Filing
- 2006-10-06 PT PT06807024T patent/PT1940409E/pt unknown
2008
- 2008-02-20 ZA ZA200801667A patent/ZA200801667B/xx unknown
- 2008-04-07 IL IL190652A patent/IL190652A/en active IP Right Grant
- 2008-05-08 KR KR1020087011117A patent/KR101344225B1/ko active IP Right Grant
2010
- 2010-12-20 CY CY20101101170T patent/CY1111022T1/el unknown
2011
- 2011-02-16 US US13/028,434 patent/US20110135582A1/en not_active Abandoned
2012
- 2012-06-29 US US13/537,589 patent/US20120263655A1/en not_active Abandoned
2013
- 2013-03-12 US US13/796,445 patent/US20130189194A1/en not_active Abandoned
- 2013-11-04 US US14/071,035 patent/US20140056823A1/en not_active Abandoned
2014
- 2014-06-12 US US14/302,780 patent/US20140286879A1/en not_active Abandoned
- 2014-12-03 US US14/559,030 patent/US20150086489A1/en not_active Abandoned
2016
- 2016-06-09 US US15/177,513 patent/US20160287600A1/en not_active Abandoned
2017
- 2017-01-23 US US15/412,251 patent/US20170128455A1/en not_active Abandoned
- 2017-08-16 US US15/678,286 patent/US20170340645A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP5081158B2 (ja)	2012-11-21
CY1111022T1 (el)	2015-06-11
NZ567547A (en)	2011-06-30
IL190652A0 (en)	2008-12-29
AU2006301329B2 (en)	2012-08-02
PL1940409T3 (pl)	2011-03-31
RU2436578C2 (ru)	2011-12-20
JP2009511541A (ja)	2009-03-19
RU2008117834A (ru)	2010-01-27
US20140286879A1 (en)	2014-09-25
DE502006007982D1 (de)	2010-11-11
WO2007042467A1 (de)	2007-04-19
IL190652A (en)	2013-10-31
BRPI0617269A2 (pt)	2011-07-19
ES2353404T3 (es)	2011-03-01
ATE482709T1 (de)	2010-10-15
US20170340645A1 (en)	2017-11-30
CA2624584C (en)	2017-01-03
KR101344225B1 (ko)	2013-12-23
US20130189194A1 (en)	2013-07-25
DK1940409T3 (da)	2010-11-29
EP1940409B1 (de)	2010-09-29
PT1940409E (pt)	2010-12-03
EP1940409A1 (de)	2008-07-09
US20140056823A1 (en)	2014-02-27
KR20080067643A (ko)	2008-07-21
TWI396541B (zh)	2013-05-21
CN101282729A (zh)	2008-10-08
AU2006301329A1 (en)	2007-04-19
US20120263655A1 (en)	2012-10-18
ZA200801667B (en)	2009-03-25
US20150086489A1 (en)	2015-03-26
TW200731975A (en)	2007-09-01
AU2006301329B9 (en)	2012-09-06
US20070086957A1 (en)	2007-04-19
US20170128455A1 (en)	2017-05-11
CA2624584A1 (en)	2007-04-19
AR057148A1 (es)	2007-11-21
US20110135582A1 (en)	2011-06-09
US20160287600A1 (en)	2016-10-06

Publication	Publication Date	Title
ZA200801667B (en)	2009-03-25	Novel pharmaceutical combinations for the treatment of respiratory disorders
IL208607A0 (en)	2010-12-30	Improved nanobodiestm for the treatment of aggregation-mediated disorders
TWI369987B (en)	2012-08-11	New pharmaceutical compositions for the treatment of hyper-proliferative disorders
IL188204A0 (en)	2008-03-20	Combination therapy for the treatment of immunoinflammatory disorders
ZA200802762B (en)	2015-11-25	Pharmaceutical compositions for the treatment of inner ear disorders
ZA200706791B (en)	2012-01-25	Isoxazole combretasin derivatives for the treatment of disorders
IL184425A0 (en)	2007-10-31	Cxcr4 antagonists for the treatment of medical disorders
IL191283A (en)	2015-03-31	Compositions for treating eye irregularities
GB0522311D0 (en)	2005-12-07	Pharmaceutical compositions for the treatment of pain
TWI372056B (en)	2012-09-11	Novel medicament combinations for the treatment of respiratory diseases
IL190338A0 (en)	2009-09-22	Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
ZA200707280B (en)	2008-12-31	Treatment of bone disorders
IL190920A0 (en)	2009-09-22	Compounds for the treatment of metabolic disorders
EP2166837A4 (en)	2011-12-21	DRUG COMBINATION USEFUL FOR THE TREATMENT OF SKIN DISORDERS
IL178815A0 (en)	2007-05-15	The treatment of respiratory disease
ZA200901523B (en)	2010-05-26	Use of extracts for the treatment of viral disorders
GB0410399D0 (en)	2004-06-16	The treatment of respiratory disease
IL185444A0 (en)	2008-01-06	Novel drugs for treating respiratory diseases
IL193799A0 (en)	2009-09-22	New therapeutic combinations for the treatment or prevention of psycotic disorders
HU0500145D0 (en)	2005-04-28	Composition for the treatment of oral diseases
GB2432586B (en)	2010-01-13	Treatment of neurodegenerative disorders
PL1982178T3 (pl)	2014-02-28	Sposoby leczenia zaburzeń afektywnych
GB0512757D0 (en)	2005-07-27	Treatment of respiratory disorders
GB0417474D0 (en)	2004-09-08	Treatment of respiratory disorders
ZA200802948B (en)	2009-01-28	Biphenyloxyacetic acid derivatives for the treatment of respiratory disease